FABINOPharmaceuticals

Fabino Enterprises LtdQuarterly Results & Earnings

15.19
+0.00%
Profit Growth YoY160.00%Latest quarter
Sales Growth YoY67.64%Latest quarter
Sales CAGR 5YN/A5 year compound
Profit CAGR 5YN/A5 year compound
📋

Quarterly Performance

YoY Profit Growth+160.00%
🔥 Exceptional growth
YoY Sales Growth+67.64%
🔥 Exceptional growth
OPM 5Y Average
Operating profit margin
N/A
EPS Growth 5Y
N/A
Interest Coverage
Higher = safer debt servicing
2.46
ROE
1.44%
ROCE
5.61%
💡

Growth Analysis

Fabino Enterprises Ltd reported YoY profit growth of 160.00% and revenue growth of 67.64% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at N/A and profits at N/A annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.